+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Marijuana Market by Product Type, Cultivation Type, Route of Administration, Application, Age Group, Distribution Channel - Global Forecast 2026-2032- Product Image
Medical Marijuana Market by Product Type, Cultivation Type, Route of Administration, Application, Age Group, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Medical Marijuana Market by Product Type, Cultivation Type, Route of Administration, Application, Age Group, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674852
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Marijuana Market is projected to reach USD 18.70 Billion in 2026. It is expected to continue growing at a CAGR of 9.14%, reaching USD 31.60 Billion by 2032.

The medical marijuana market is moving from advocacy-led adoption to evidence-led healthcare integration. Demand is anchored by patients and clinicians seeking cannabinoid-based therapies for conditions where conventional options may be insufficient, including chemotherapy-induced nausea, multiple sclerosis spasticity, epilepsy syndromes treated with prescription cannabidiol, and chronic pain management under jurisdiction-specific rules.

Verified policy milestones continue to shape the sector. Canada legalized adult-use cannabis federally in 2018 while maintaining medical access; the U.S. Food and Drug Administration has approved cannabis-derived and synthetic cannabinoid medicines, including cannabidiol oral solution for specific seizure disorders and dronabinol and nabilone products for approved indications; and the United Nations Commission on Narcotic Drugs voted in 2020 to remove cannabis from Schedule IV of the 1961 Single Convention while keeping it internationally controlled. These developments support a more regulated medical cannabis ecosystem built around quality, traceability, clinical evidence, and patient safety.

Transformative Shifts in the Medical Cannabis Landscape

The medical marijuana landscape is being transformed by the convergence of regulatory modernization, pharmaceutical-grade manufacturing, and patient demand for standardized cannabinoid therapies. Countries that once relied on exceptional-access programs are increasingly building formal medical cannabis pathways, while established markets are tightening requirements around product testing, labeling accuracy, contamination control, and prescriber oversight.

A second shift is the separation of medical marijuana from general consumer cannabis. Healthcare systems, insurers, hospital formularies, and regulators are prioritizing products with defined cannabinoid profiles, reproducible dosing, and documented safety monitoring. As a result, operators that can demonstrate Good Manufacturing Practice alignment, pharmacovigilance discipline, and credible clinical data are better positioned than participants competing solely on flower volume or retail footprint.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding cumulative value across the medical marijuana value chain by improving evidence review, cultivation consistency, manufacturing quality, and patient support. AI-enabled literature mining can help research teams monitor cannabinoid studies, adverse-event signals, and drug-interaction evidence more efficiently, while machine learning models can support controlled-environment agriculture through climate optimization, pest detection, and yield forecasting.

In commercial and clinical operations, AI is most valuable when governed by validated data, human oversight, and privacy safeguards. Medical cannabis organizations are applying analytics to inventory planning, batch-release trends, patient-reported outcomes, and regulatory documentation. The strategic advantage is not replacing clinical judgment, but converting fragmented cultivation, dispensing, and real-world evidence data into auditable insights that improve compliance and therapeutic consistency.

Key Regional Insights: Global Medical Marijuana Demand

Asia-Pacific is characterized by selective legalization and strong pharmaceutical oversight, with Australia operating a regulated medical cannabis access system through prescription and special-access pathways, while several Asian jurisdictions maintain strict narcotics controls. North America remains the most mature regulated commercial region because Canada has federal medical and adult-use frameworks and the United States has broad state-level medical cannabis access despite continuing federal restrictions under the Controlled Substances Act.

Latin America is important as both a patient-access and cultivation region, with countries such as Brazil, Mexico, and Colombia shaping policy through health-agency approvals, court decisions, import pathways, and licensing models. Europe is advancing through prescription-based systems, with Germany representing a major reference point after expanding access and reforming cannabis law in 2024, while the United Kingdom, France, Italy, Spain, and other markets maintain more controlled medical channels.

The Middle East and Africa show uneven but strategically relevant development. Some Middle Eastern markets remain highly restrictive, while Israel has long-standing medical cannabis research and patient access experience. In Africa, Lesotho, South Africa, and selected jurisdictions have pursued medical cannabis cultivation, licensing, or patient access initiatives, although export compliance, domestic affordability, and regulatory capacity remain central constraints.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN remains one of the most restrictive regional blocs for cannabis, although Thailand’s policy opening created a notable test case for medical and wellness-related cannabis regulation before subsequent policy tightening discussions. The GCC is generally conservative because narcotics laws are strict across Gulf states, making compliant pharmaceutical cannabinoid products a more plausible pathway than broad dispensary-based models.

The European Union is a critical regulatory reference area because member states apply national medical cannabis laws within broader EU standards for medicines, quality systems, pharmacovigilance, and cross-border trade. BRICS markets show divergent profiles: China has industrial hemp activity but strict cannabis control, India has traditional cannabis-related regulatory complexity, Brazil is expanding health-agency governed access, Russia remains restrictive, and South Africa has developed medical and cultivation frameworks.

G7 markets concentrate much of the world’s regulated medical cannabis spending, clinical research capacity, and investor attention through the United States, Canada, Germany, the United Kingdom, France, Italy, and Japan’s tightly controlled pharmaceutical environment. NATO members overlap significantly with North American and European markets, where compliance, pharmaceutical supply chains, and security standards influence procurement, research collaborations, and cross-border investment.

Key Country Insights: Priority Medical Marijuana Markets

The United States is the largest opportunity by patient population and state-level program breadth, yet federal Schedule I status has historically constrained banking, interstate commerce, tax treatment, and research. Canada provides one of the clearest federally regulated benchmarks, while Mexico and Brazil continue to evolve through health-authority and court-driven access models that emphasize imports, prescriptions, and regulated products.

In Europe, the United Kingdom permits specialist-prescribed cannabis-based products, Germany is a central growth market due to statutory health insurance reimbursement pathways and recent legal reforms, France has moved cautiously through medical cannabis experimentation, Italy uses military and import channels, Spain relies heavily on a limited pharmaceutical and regional framework, and Russia remains highly restrictive. These differences make country-level regulatory diligence essential for market entry.

Across Asia-Pacific, China maintains strict cannabis controls while supporting industrial hemp in selected provinces, India’s opportunity is shaped by traditional use and narcotics regulation, Japan permits tightly controlled cannabinoid pharmaceutical pathways while restricting THC, Australia has one of the region’s more established medical cannabis access systems, and South Korea allows limited access to approved cannabis-based medicines under government oversight.

Actionable Recommendations for Medical Cannabis Leaders

Industry leaders should prioritize medical credibility over rapid assortment expansion. The most resilient strategies include validated quality systems, cannabinoid-profile consistency, stability data, contaminant testing, prescriber education, and pharmacovigilance. Organizations entering new countries should map narcotics law, medicine law, import requirements, advertising restrictions, and reimbursement rules before committing capital.

Executives should also invest in real-world evidence, AI-supported compliance analytics, and patient-support infrastructure that respects health-data privacy. Strategic partnerships with universities, contract research organizations, hospital networks, and GMP-certified manufacturers can improve evidence generation while reducing execution risk in a market where regulation, clinical trust, and supply reliability determine durable advantage.

Research Methodology

This executive summary is based on a secondary research methodology using verified public-domain sources, including national health agencies, medicines regulators, international drug-control policy references, peer-reviewed clinical literature, and official cannabis program documentation. The analysis emphasizes regulatory status, approved therapeutic uses, access pathways, quality requirements, and regional commercialization patterns.

Data interpretation follows a triangulation approach, comparing policy milestones, clinical evidence, and market-structure indicators across regions and country clusters. Claims are limited to documented developments and observable industry practices, with forward-looking implications framed as strategic considerations rather than unsupported forecasts.

Conclusion

Medical marijuana is becoming a more regulated, clinically scrutinized, and technology-enabled healthcare category. The strongest pathways are likely to favor organizations that can meet pharmaceutical expectations while navigating country-specific cannabis laws and patient-access models.

As regulators demand better evidence and patients seek consistent outcomes, the market’s center of gravity is shifting toward standardized cannabinoid therapeutics, compliant supply chains, and data-driven care models. Leaders that combine science, quality, and responsible commercialization will be best positioned in the global medical cannabis market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Marijuana Market, by Product Type
7.1. Capsules
7.2. Concentrates
7.3. Edibles
7.3.1. Solid
7.3.2. Beverages
7.3.3. Powders & Mixes
7.4. Flower
7.5. Topicals
7.5.1. Creams & Lotions
7.5.2. Balms & Salves
7.5.3. Transdermal Patches
7.6. Extracts & Concentrates
7.6.1. Oils
7.6.2. Tinctures
7.6.3. . Resins & Waxes
8. Medical Marijuana Market, by Cultivation Type
8.1. Greenhouse Cultivation
8.2. Indoor Cultivation
8.3. Outdoor Cultivation
9. Medical Marijuana Market, by Route of Administration
9.1. Inhalation
9.2. Oral
9.3. Topical
10. Medical Marijuana Market, by Application
10.1. Cancer
10.2. Chronic Pain
10.3. Neurological & Mental Health Disorders
10.3.1. Multiple sclerosis
10.3.2. Parkinson’s Disease
10.3.3. Anxiety & PTSD
10.3.4. Depression
10.4. Sleep Disorders
10.5. Gastrointestinal Disorders
11. Medical Marijuana Market, by Age Group
11.1. Adult
11.2. Pediatric
11.3. Geriatric
12. Medical Marijuana Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Asia-Pacific Medical Marijuana Market
14. North America Medical Marijuana Market
15. Latin America Medical Marijuana Market
16. Europe Medical Marijuana Market
17. Middle East Medical Marijuana Market
18. Africa Medical Marijuana Market
19. ASEAN Medical Marijuana Market
20. GCC Medical Marijuana Market
21. European Union Medical Marijuana Market
22. BRICS Medical Marijuana Market
23. G7 Medical Marijuana Market
24. NATO Medical Marijuana Market
25. United States Medical Marijuana Market
26. Canada Medical Marijuana Market
27. Mexico Medical Marijuana Market
28. Brazil Medical Marijuana Market
29. United Kingdom Medical Marijuana Market
30. Germany Medical Marijuana Market
31. France Medical Marijuana Market
32. Russia Medical Marijuana Market
33. Italy Medical Marijuana Market
34. Spain Medical Marijuana Market
35. China Medical Marijuana Market
36. India Medical Marijuana Market
37. Japan Medical Marijuana Market
38. Australia Medical Marijuana Market
39. South Korea Medical Marijuana Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Acreage Holdings Inc.
41.2. Ascend Wellness Holdings Inc.
41.3. Aurora Cannabis Inc.
41.4. Ayr Wellness Inc.
41.5. Botanix Pharmaceuticals Ltd.
41.6. Canopy Growth Corporation
41.7. Cantourage Group SE
41.8. Cresco Labs Inc.
41.9. Cronos Group Inc.
41.10. Curaleaf Holdings Inc.
41.11. Glass House Brands Inc.
41.12. Green Thumb Industries Inc.
41.13. GrowGeneration Corp
41.14. High Tide Inc.
41.15. Innovative Industrial Properties Inc
41.16. InterCure Ltd.
41.17. Jazz Pharmaceuticals plc
41.18. Jushi Holdings Inc.
41.19. MariMed Inc.
41.20. Organigram Holdings Inc.
41.21. Planet 13 Holdings Inc.
41.22. SNDL Inc.
41.23. TerrAscend Corp
41.24. Tilray Brands Inc.
41.25. Trulieve Cannabis Corp.
41.26. Verano Holdings Corp.
41.27. Village Farms International Inc.
List of Figures
FIGURE 1. GLOBAL MEDICAL MARIJUANA MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MEDICAL MARIJUANA MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MEDICAL MARIJUANA MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MEDICAL MARIJUANA MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MEDICAL MARIJUANA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL MEDICAL MARIJUANA MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 25. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MEDICAL MARIJUANA MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MEDICAL MARIJUANA MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL MEDICAL MARIJUANA MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONCENTRATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONCENTRATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EDIBLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EDIBLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EDIBLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SOLID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SOLID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BEVERAGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BEVERAGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BEVERAGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL POWDERS & MIXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL POWDERS & MIXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL POWDERS & MIXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FLOWER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FLOWER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FLOWER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TOPICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TOPICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TOPICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BALMS & SALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BALMS & SALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BALMS & SALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EXTRACTS & CONCENTRATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EXTRACTS & CONCENTRATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EXTRACTS & CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL OILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL OILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL OILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TINCTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TINCTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TINCTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL . RESINS & WAXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL . RESINS & WAXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL . RESINS & WAXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GREENHOUSE CULTIVATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GREENHOUSE CULTIVATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GREENHOUSE CULTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INDOOR CULTIVATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INDOOR CULTIVATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INDOOR CULTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OUTDOOR CULTIVATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OUTDOOR CULTIVATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OUTDOOR CULTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEUROLOGICAL & MENTAL HEALTH DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEUROLOGICAL & MENTAL HEALTH DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEUROLOGICAL & MENTAL HEALTH DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANXIETY & PTSD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANXIETY & PTSD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANXIETY & PTSD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL SLEEP DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL SLEEP DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 155. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 157. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 161. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 162. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 177. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 178. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 179. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 181. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 184. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 187. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 188. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 189. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 190. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 194. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. GCC MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GCC MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. GCC MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 199. GCC MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 200. GCC MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 201. GCC MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203. GCC MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. GCC MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 205. GCC MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 206. GCC MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. BRICS MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. BRICS MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. BRICS MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 221. BRICS MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 222. BRICS MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 223. BRICS MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRICS MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. BRICS MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. BRICS MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 227. BRICS MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 228. BRICS MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. G7 MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 230. G7 MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 232. G7 MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 233. G7 MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 234. G7 MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 235. G7 MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. G7 MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. G7 MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 238. G7 MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 239. G7 MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. NATO MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 241. NATO MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. NATO MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 243. NATO MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 244. NATO MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 245. NATO MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 246. NATO MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 247. NATO MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. NATO MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 249. NATO MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 250. NATO MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. CANADA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. CANADA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 264. CANADA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 265. CANADA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 266. CANADA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 267. CANADA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 268. CANADA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 269. CANADA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. CANADA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 271. CANADA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 272. CANADA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 273. MEXICO MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 274. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 276. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 277. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 278. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 279. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 280. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 281. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 282. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 283. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 284. BRAZIL MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 285. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 287. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 288. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 289. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 290. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 291. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 293. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 294. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 300. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 301. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 302. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 304. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 305. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 306. GERMANY MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 307. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 308. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 309. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 310. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 311. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 312. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 313. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 314. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 315. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 316. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 317. FRANCE MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 318. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 319. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 320. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 321. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 322. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 323. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 324. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 325. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 326. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 327. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 328. RUSSIA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 330. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 331. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 332. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 333. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 334. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 335. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 336. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 337. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 338. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 339. ITALY MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 340. ITALY MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 341. ITALY MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 342. ITALY MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 343. ITALY MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 344. ITALY MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 345. ITALY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 346. ITALY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 347. ITALY MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 348. ITALY MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 349. ITALY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 350. SPAIN MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 351. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 352. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 353. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 354. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
TABLE 355. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2018-2032 (USD MILLION)
TABLE 356. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 357. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 358. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
TABLE 359. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 360. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 361. CHINA MEDICAL MARIJUANA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 362. CHINA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 363. CHINA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2018-2032 (USD MILLION)
TABLE 364. CHINA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 365. CHINA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2018-2032 (USD MILLION)
T

Companies Mentioned

The companies featured in this Medical Marijuana market report include:
  • Acreage Holdings Inc.
  • Ascend Wellness Holdings Inc.
  • Aurora Cannabis Inc.
  • Ayr Wellness Inc.
  • Botanix Pharmaceuticals Ltd.
  • Canopy Growth Corporation
  • Cantourage Group SE
  • Cresco Labs Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings Inc.
  • Glass House Brands Inc.
  • Green Thumb Industries Inc.
  • GrowGeneration Corp
  • High Tide Inc.
  • Innovative Industrial Properties Inc
  • InterCure Ltd.
  • Jazz Pharmaceuticals plc
  • Jushi Holdings Inc.
  • MariMed Inc.
  • Organigram Holdings Inc.
  • Planet 13 Holdings Inc.
  • SNDL Inc.
  • TerrAscend Corp
  • Tilray Brands Inc.
  • Trulieve Cannabis Corp.
  • Verano Holdings Corp.
  • Village Farms International Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 18.7 Billion
Forecasted Market Value ( USD ) by 2032 $ 31.6 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Legal Marijuana Market by Product Type, Route of Administration, Application - Global Forecast 2026-2032 - Product Image

Legal Marijuana Market by Product Type, Route of Administration, Application - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Marijuana Market by Product Type, Strain Type, Chemical Composition, Processing, Application - Global Forecast 2026-2032 - Product Image

Marijuana Market by Product Type, Strain Type, Chemical Composition, Processing, Application - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Medical Marijuana - Global Strategic Business Report - Product Image

Medical Marijuana - Global Strategic Business Report

  • Report
  • 154 Pages
  • Global
From
Medical Marijuana: Market Share, and Growth Analysis by Product Type (Flower, Oils, Edibles), Application, End User, Technology - Product Image

Medical Marijuana: Market Share, and Growth Analysis by Product Type (Flower, Oils, Edibles), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Legal Marijuana Market Report and Forecast 2025-2034 - Product Image

Legal Marijuana Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.